Detalhe da pesquisa
1.
Implementation of a broad public health approach to COVID-19 in Sweden, January 2020 to May 2022.
Euro Surveill
; 28(41)2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37824250
2.
Point prevalence of SARS-CoV-2 infection in Sweden at six time points during 2020.
BMC Infect Dis
; 22(1): 861, 2022 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36396981
3.
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020.
Euro Surveill
; 25(9)2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32156327
4.
Temporal Dynamics and Risk Factors for Bloodstream Infection With Extended-spectrum ß-Lactamase-producing Bacteria in Previously-colonized Individuals: National Population-based Cohort Study.
Clin Infect Dis
; 68(4): 641-649, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29961883
5.
Lessons learnt during 20 years of the Swedish strategic programme against antibiotic resistance.
Bull World Health Organ
; 95(11): 764-773, 2017 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29147057
6.
Carbapenemase-producing Enterobacteriaceae in Sweden 2007-2013: Experiences from seven years of systematic surveillance and mandatory reporting.
Drug Resist Updat
; 20: 29-38, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26004211
7.
Seroprevalence of SARS-CoV-2 in Sweden, April 26 to May 9, 2021.
Sci Rep
; 12(1): 10816, 2022 06 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35752708
8.
[Focus on improved antibiotics use in the government's patient safety initiative]. / Förbättrad antibiotikaanvändning i fokus i regeringens patientsäkerhetssatsning.
Lakartidningen
; 108(3): 96-7, 2011.
Artigo
em Sueco
| MEDLINE | ID: mdl-21381267
9.
Knowledge and Attitudes towards Antibiotic Use and Resistance - A Latent Class Analysis of a Swedish Population-Based Sample.
PLoS One
; 11(4): e0152160, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27096751
10.
Six-week follow-up after HIV-1 exposure: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy.
Infect Dis (Lond)
; 48(2): 93-8, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26414596
11.
Plasmidome-analysis of ESBL-producing escherichia coli using conventional typing and high-throughput sequencing.
PLoS One
; 8(6): e65793, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23785449
12.
Identification of Klebsiella pneumoniae carbapenemase in Sweden.
Euro Surveill
; 12(12): E071220.3, 2007 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-18179763
13.
Lessons learnt during 20 years of the Swedish strategic programme against antibiotic resistance
Bull. W.H.O. (Print)
; 95(11): 764-773, 2017-11-01.
Artigo
em Inglês
| WHOLIS | ID: who-272161
14.
Coordinated and differential control of aureolysin (aur) and serine protease (sspA) transcription in Staphylococcus aureus by sarA, rot and agr (RNAIII).
Int J Med Microbiol
; 296(6): 365-80, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16782403
15.
Natural human isolates of Staphylococcus aureus selected for high production of proteases and alpha-hemolysin are sigmaB deficient.
Int J Med Microbiol
; 296(4-5): 229-36, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16530010
16.
SarA is a repressor of hla (alpha-hemolysin) transcription in Staphylococcus aureus: its apparent role as an activator of hla in the prototype strain NCTC 8325 depends on reduced expression of sarS.
J Bacteriol
; 188(24): 8526-33, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17012389